C3 and cancer: Furthermore, the ability to rapidly synthesize and conjugate custom peptides to the exterior of our complement C3-targeted liposomes makes this delivery system potentially useful in future scenarios, such as for vaccines in emerging epidemics with rapidly evolving organisms or for personalized cancer immunotherapy targeting identified neoantigens in rapidly mutating tumors.